"Following the enormous political, legal, and media interest that has surrounded high profile cases of whistleblowing, such as Chelsea Manning and Edward Snowden, the fundamental ethical questions surrounding whistleblowing have often been obscured. [This book] examines the ethi…
Following the enormous political, legal, and media interest that has surrounded high profile cases of whistleblowing, such as Chelsea Manning and Edward Snowden, the fundamental ethical questions surrounding whistleblowing have often been obscured. In this fascinating book Eric …
Overview: From Erin Brockovich to Enron, whistleblowers who "challenge abuses of power that betray the public trust" have proven to be an unfortunate necessity in modern business culture. Their efforts to report crimes, fraud, and dangers to public health and safety have saved m…
Overview: From Erin Brockovich to Enron, whistleblowers who "challenge abuses of power that betray the public trust" have proven to be an unfortunate necessity in modern business culture. Their efforts to report crimes, fraud, and dangers to public health and safety have saved m…
"Stephen Kohn presents a comprehensive, unified examination of the 35 federal laws that protect whistleblowers and their rights plus the common law protections available in each of the 50 states. For the first time in one easily accessed volume, readers will find the basic princ…
Litigator, teacher, and scholar Stephen Kohn presents a comprehensive, unified examination of the 35 federal laws that protect whistleblowers and their rights, plus the common law protections available in each of the 50 states. For the first time in one easily accessed volume, r…
Solid guidance for managing whistleblower policies in light of the new Dodd-Frank Act provisions In July 2010, President Obama signed the Dodd-Frank Wall Street Reform and Consumer Protection Act that greatly expanded whistleblower bounties in connection with violations of feder…
"The book will discuss business protection strategies and best practices in dealing with whistleblowers, as well as the GlaxoSmithKline, Pfizer and other high profile whistleblower cases. The book is expected to appeal to Board members, C-Suite executives, corporate compliance p…
"The book will discuss business protection strategies and best practices in dealing with whistleblowers, as well as the GlaxoSmithKline, Pfizer and other high profile whistleblower cases. The book is expected to appeal to Board members, C-Suite executives, corporate compliance p…
"The book will discuss business protection strategies and best practices in dealing with whistleblowers, as well as the GlaxoSmithKline, Pfizer and other high profile whistleblower cases. The book is expected to appeal to Board members, C-Suite executives, corporate compliance p…
"The book will discuss business protection strategies and best practices in dealing with whistleblowers, as well as the GlaxoSmithKline, Pfizer and other high profile whistleblower cases. The book is expected to appeal to Board members, C-Suite executives, corporate compliance p…